The API industry has entered the 3.0 era,it is neccessary to shift from traditional APIs to high-barrier specialty APIs,patented APIs, and biopharmaceutical raw materials.

By overcoming more complex synthesis processes and meeting stricter regulatory standards, we aim to integrate into the global high-value pharmaceutical industry chain. This represents a crucial leap from “cost competition” À “competition based on technology and quality”.

Our GMP projects for specific API will be carried out according to market and customers’ demand to cater to the 3.0 era.